我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Exploring the Interplay of Immunity and Disease: Immuno-Epidemiology in Public Health

Renuka D

The field of immuno-epidemiology has emerged as a crucial area of research within public health, aiming to unravel the intricate relationship between immunity and disease. This abstract highlights the significance of investigating this interplay and its implications for improving population health outcomes. In recent years, advancements in understanding the human immune system and its role in disease susceptibility and progression have revolutionized the field of public health. Immuno-epidemiology, an interdisciplinary approach that combines immunology and epidemiology, seeks to elucidate the complex mechanisms by which immunity influences disease dynamics at the population level. This abstract underscores the importance of immuno-epidemiology in public health by showcasing its potential impact on disease prevention, control, and management strategies. By studying how the immune system responds to various pathogens, vaccines, and environmental factors, researchers can gain insights into the dynamics of infectious diseases, chronic conditions, and the impact of immunization programs on population health. Furthermore, immuno-epidemiology provides a framework to explore the immune correlates of protection, helping to guide the development of effective vaccines and immunotherapies. By understanding the determinants of immune response heterogeneity, researchers can optimize vaccine strategies, identify at-risk populations, and tailor interventions accordingly. This abstract also emphasizes the importance of immuno-epidemiological studies in the context of emerging infectious diseases, such as viral outbreaks or antimicrobial resistance. Rapidly evolving pathogens pose unique challenges to public health, and immuno-epidemiology offers valuable tools for surveillance, risk assessment, and response planning.